St. Louis encephalitis secondary prevention

St. Louis encephalitis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating St. Louis encephalitis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
St. Louis encephalitis secondary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of St. Louis encephalitis secondary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on St. Louis encephalitis secondary prevention
CDC on St. Louis encephalitis secondary prevention
St. Louis encephalitis secondary prevention in the news
Blogs on St. Louis encephalitis secondary prevention
Directions to Hospitals Treating St. Louis encephalitis
Risk calculators and risk factors for St. Louis encephalitis secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anthony Gallo, B.S. [2]; Contributor(s): Irfan Dotani [3]

Overview

Secondary prevention strategies following Saint Louis encephalitis virus include interpheron alpha-2b.

Secondary Prevention

Secondary prevention strategies following Saint Louis encephalitis virus include interpheron alpha-2b. The early usage of Interferon may decrease the severity of the complications.

For more information on mosquito protection, visit American Mosquito Control Association. For more case studies on interferon-alpha2b, visit